Zhao-dong Han

Guangzhou, 510180, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

N1-methyladenosine RNA methylation patterns are associated with an increased risk to biochemical recurrence in prostate cancer and serve as a potential novel biomarker for patient stratification.

N1-methyladenosine RNA methylation patterns are associated with an increased risk to biochemical recurrence in prostate cancer and serve as a potential novel biomarker for patient stratification.

Journal: International immunopharmacology

Published: April 22, 2024

Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

Journal: Molecular cancer

Published: March 21, 2023

Mannose inhibits the growth of prostate cancer through a mitochondrial mechanism.

Mannose inhibits the growth of prostate cancer through a mitochondrial mechanism.

Journal: Asian journal of andrology

Published: February 10, 2022

Novel immune-related signature for risk stratification and prognosis in prostatic adenocarcinoma.

Novel immune-related signature for risk stratification and prognosis in prostatic adenocarcinoma.

Journal: Cancer science

Published: February 06, 2021

ARNT-dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer.

ARNT-dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer.

Journal: Molecular carcinogenesis

Published: August 21, 2019

Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

Journal: Molecular cancer

Published: August 08, 2019

TRIB1 induces macrophages to M2 phenotype by inhibiting IKB-zeta in prostate cancer.

TRIB1 induces macrophages to M2 phenotype by inhibiting IKB-zeta in prostate cancer.

Journal: Cellular signalling

Published: January 01, 2019

Upregulation of Holliday junction recognition protein predicts poor prognosis and biochemical recurrence in patients with prostate cancer.

Upregulation of Holliday junction recognition protein predicts poor prognosis and biochemical recurrence in patients with prostate cancer.

Journal: Oncology letters

Published: August 20, 2018

Functional classification of prostate cancer‑associated miRNAs through CRISPR/Cas9‑mediated gene knockout.

Functional classification of prostate cancer‑associated miRNAs through CRISPR/Cas9‑mediated gene knockout.

Journal: Molecular medicine reports

Published: May 06, 2018

Expression of PD-L1 in tumor-associated nerves correlates with reduced CD8+ tumor-associated lymphocytes and poor prognosis in prostate cancer.

Expression of PD-L1 in tumor-associated nerves correlates with reduced CD8+ tumor-associated lymphocytes and poor prognosis in prostate cancer.

Journal: International journal of cancer

Published: April 07, 2018

Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer.

Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer.

Journal: Journal of cellular biochemistry

Published: October 22, 2017

Overexpression of TPX2 is associated with progression and prognosis of prostate cancer.

Overexpression of TPX2 is associated with progression and prognosis of prostate cancer.

Journal: Oncology letters

Published: September 21, 2017

Showing 1-12 of 37

Last Updated: 09/26/2026